Theriva Biologics (FRA:SFY0) GF Score: 24/100 (As of Jul. 12, 2026) — 27% Below Median


FRA:SFY0 Theriva Biologics Inc FRA:SFY0
24 GF Score
Price €2.42
! 3 Warning Signs
View Full Analysis

What is Theriva Biologics GF Score?

Theriva Biologics FRA:SFY0 24 GF Score is 24 as of Jul. 12, 2026, which is 27% below its 10-year median of 33.00. GuruFocus rates FRA:SFY0 with a GF Score™ of 24/100. The stock has 3 warning signs investors should review.

Theriva Biologics has the GF Score of 24, which implies that the company might have Worst future performance potential, or not enough data.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 3/10
2. Profitability Rank : 1/10
3. Growth Rank : 0/10
4. GF Value Rank : 0/10
5. Momentum Rank : 4/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes Theriva Biologics might have Worst future performance potential, or not enough data.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Theriva Biologics  (FRA:SFY0) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score Performance Potential and All-in-One Screener Examples (1)
91 - 100Highest outperformance potential
81 - 90Good outperformance potential
71 - 80Likely to have average performance
51 - 70Poor future performance potential
0 - 50Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.

Theriva Biologics GF Score Related Terms

FRA:SFY0 vs OSRH, PBM, PHIO: GF Score Comparison

For the Biotechnology subindustry, Theriva Biologics's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Theriva Biologics GF Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Theriva Biologics's GF Score distribution charts can be found below:

* The bar in red indicates where Theriva Biologics's GF Score falls into.


FRA:SFY0
24GF Score
Theriva Biologics Inc FRA:SFY0
GF Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Score →
What does a GF Score of 24 mean?
Theriva Biologics (FRA:SFY0) has a GF Score of 24 as of Jul. 12, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Theriva Biologics and its competitors. This is 27% below median its historical median of 33.00. Over the past decade, Theriva Biologics' GF Score has ranged from 17.00 to 41.00.
Is Theriva Biologics' GF Score too high?
Theriva Biologics' current GF Score of 24 is 27% below median its 10-year median of 33.00. Over the past 10 years, this metric has ranged from a low of 17.00 to a high of 41.00. Overall, Theriva Biologics has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Theriva Biologics' GF Score compare to OSRH and PBM?
Theriva Biologics' GF Score of 24 can be compared against companies in the Biotechnology industry. Historically, Theriva Biologics' own GF Score has ranged from 17.00 to 41.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Biotechnology company?
A good GF Score depends on the Biotechnology industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Theriva Biologics and its competitors. Theriva Biologics's current GF Score is 24, which is 27% below median its own 10-year median of 33.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Theriva Biologics stock overvalued right now?
Theriva Biologics (FRA:SFY0) has a current GF Score of 24. The current GF Score is 24, which is 27% below median its 10-year median of 33.00. Theriva Biologics' overall GF Score™ is 24/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For Theriva Biologics (FRA:SFY0), the current GF Score is 24 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Theriva Biologics Business Description

Other Exchanges TOVX:USA
Address 9605 Medical Center Drive, Suite 270, Rockville, MD, USA, 20850
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system. Product Candidates includes SYN-004 (ribaxamase) and SYN-020.
24GF Score

Get the complete analysis for FRA:SFY0

GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.42
Price